Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor

被引:1
|
作者
Garcia, DE
Brown, S
Hille, B
Mackie, K
机构
[1] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA
[2] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA
[3] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Mexico City 04510, DF, Mexico
来源
JOURNAL OF NEUROSCIENCE | 1998年 / 18卷 / 08期
关键词
cannabinoid; G-protein-coupled receptor; calcium channel; inwardly rectifying potassium channel; protein kinase C; phosphorylation;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We have found that phosphorylation of a G-protein-coupled receptor by protein kinase C (PKC) disrupts modulation of ion channels by the receptor. In AtT-20 cells transfected with rat cannabinoid receptor (CB1), the activation of an inwardly rectifying potassium current (K-ir current) and depression of P/Q-type calcium channels by cannabinoids were prevented by stimulation of protein kinase C by 100 nM phorbol 12-myristate 13-acetate (PMA). In contrast, activation of K-ir current by somatostatin was unaffected, and inhibition of calcium channels was only modestly attenuated. The possibility that PKC acted by phosphorylating CB1 receptors was confirmed by demonstrating that PKC phosphorylated a single serine (S317) of a fusion protein incorporating the third intracellular loop of CB1. Mutating this serine to alanine did not affect the ability of CB1 to modulate currents, but it eliminated disruption by PMA, demonstrating that PKC can disrupt ion channel modulation by receptor phosphorylation.
引用
收藏
页码:2834 / 2841
页数:8
相关论文
共 50 条
  • [31] CB1 Cannabinoid Receptor Signaling and Biased Signaling
    Leo, Luciana M.
    Abood, Mary E.
    MOLECULES, 2021, 26 (17):
  • [32] Pentacycle derivatives as cannabinoid CB1 receptor ligands
    Lee, Suk Ho
    Seo, Hee Jeong
    Kim, Min Ju
    Kang, Suk Youn
    Lee, Sung-Han
    Ahn, Kwangwoo
    Lee, MinWoo
    Han, Ho-Kyun
    Kim, Jeongmin
    Lee, Jinhwa
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (23) : 6632 - 6636
  • [33] Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
    Austrich-Olivares, Amaya
    Salud Garcia-Gutierrez, Maria
    Illescas, Lucia
    Gasparyan, Ani
    Manzanares, Jorge
    PHARMACEUTICALS, 2022, 15 (04)
  • [34] The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum
    Kawamura, Y
    Fukaya, M
    Maejima, T
    Yoshida, T
    Miura, E
    Watanabe, M
    Ohno-Shosaku, T
    Kano, M
    JOURNAL OF NEUROSCIENCE, 2006, 26 (11): : 2991 - 3001
  • [35] Binding Modes and Selectivity of Cannabinoid 1 (CB1) and Cannabinoid 2 (CB2) Receptor Ligands
    Yang, Jing-Fang
    Williams, Alexander H.
    Penthala, Narsimha R.
    Prather, Paul L.
    Crooks, Peter A.
    Zhan, Chang-Guo
    ACS CHEMICAL NEUROSCIENCE, 2020, 11 (20): : 3455 - 3463
  • [36] Crystal Structure of the Human Cannabinoid Receptor CB1
    Hua, Tian
    Vemuri, Kiran
    Pu, Mengchen
    Qu, Lu
    Han, Gye Won
    Wu, Yiran
    Zhao, Suwen
    Shui, Wenqing
    Li, Shanshan
    Korde, Anisha
    Laprairie, Robert B.
    Stahl, Edward L.
    Ho, Jo-Hao
    Zvonok, Nikolai
    Zhou, Han
    Kufareva, Irina
    Wu, Beili
    Zhao, Qiang
    Hanson, Michael A.
    Bohn, Laura M.
    Makriyannis, Alexandros
    Stevens, Raymond C.
    Liu, Zhi-Jie
    CELL, 2016, 167 (03) : 750 - +
  • [37] Cannabinoid CB1 Receptor and Gastric Acid Secretion
    Francesca Borrelli
    Digestive Diseases and Sciences, 2007, 52 : 3102 - 3103
  • [38] Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB1 receptor
    Ryalls, Beth
    Patel, Monica
    Sparkes, Eric
    Banister, Samuel D.
    Finlay, David B.
    Glass, Michelle
    BIOCHEMICAL PHARMACOLOGY, 2024, 222
  • [39] Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction
    Gardner, Eliot L.
    Bi, Guo-Hua
    Thakur, Ganesh
    Makriyannis, Alexandros
    Seltzman, Herbert H.
    He, Xiang-Hu
    Xi, Zheng-Xiong
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 152 - 152
  • [40] Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice
    Aníbal Sánchez-de la Torre
    Tania Aguado
    Alba Huerga-Gómez
    Silvia Santamaría
    Antonietta Gentile
    Juan Carlos Chara
    Carlos Matute
    Krisztina Monory
    Susana Mato
    Manuel Guzmán
    Beat Lutz
    Ismael Galve-Roperh
    Javier Palazuelos
    Cell Death & Disease, 13